NO prodrug-conjugated, self-assembled, pH-responsive and galactose receptor targeted nanoparticles for co-delivery of nitric oxide and doxorubicin
Nitric oxide (NO) prodrug-conjugated, acid-responsive and galactose receptor targeted nanoparticles were developed for the co-delivery of NO and doxorubicin.
2009 ◽
Vol 13
(01)
◽
pp. 35-40
◽
2012 ◽
Vol 50
◽
pp. 416-427
◽
Keyword(s):
2016 ◽
Vol 64
◽
pp. 346-353
◽
Keyword(s):
2020 ◽
Vol 163
◽
pp. 1106-1116